List of Tables
Table 1. Global Functional Dyspepsia Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Functional Dyspepsia Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 5. Global Functional Dyspepsia Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Functional Dyspepsia Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Functional Dyspepsia Drug Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Functional Dyspepsia Drug Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Functional Dyspepsia Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Functional Dyspepsia Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Functional Dyspepsia Drug Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Functional Dyspepsia Drug Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Functional Dyspepsia Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Functional Dyspepsia Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Functional Dyspepsia Drug Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Functional Dyspepsia Drug Sales Share by Manufacturer (2020-2025)
Table 18. Functional Dyspepsia Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Functional Dyspepsia Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Functional Dyspepsia Drug Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Functional Dyspepsia Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2024)
Table 24. Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
Table 26. Manufacturers Functional Dyspepsia Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Bayer Company Information
Table 29. Bayer Description and Business Overview
Table 30. Bayer Functional Dyspepsia Drug Product
Table 31. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Bayer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 33. Bayer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 34. Bayer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 35. Bayer Recent Developments
Table 36. Sumitomo Company Information
Table 37. Sumitomo Description and Business Overview
Table 38. Sumitomo Functional Dyspepsia Drug Product
Table 39. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 41. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 42. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 43. Sumitomo Recent Developments
Table 44. Cadila Pharmaceuticals Company Information
Table 45. Cadila Pharmaceuticals Description and Business Overview
Table 46. Cadila Pharmaceuticals Functional Dyspepsia Drug Product
Table 47. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 49. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 50. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 51. Cadila Pharmaceuticals Recent Developments
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Functional Dyspepsia Drug Product
Table 55. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Teva Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 57. Teva Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 58. Teva Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 59. Teva Recent Developments
Table 60. Johnson & Johnson Company Information
Table 61. Johnson & Johnson Description and Business Overview
Table 62. Johnson & Johnson Functional Dyspepsia Drug Product
Table 63. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 65. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 66. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 67. Johnson & Johnson Recent Developments
Table 68. Pfizer Company Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Functional Dyspepsia Drug Product
Table 71. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 73. Pfizer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 74. Pfizer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 75. Pfizer Recent Developments
Table 76. Sanofi Company Information
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Functional Dyspepsia Drug Product
Table 79. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 81. Sanofi Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 82. Sanofi Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 83. Sanofi Recent Developments
Table 84. AstraZeneca Company Information
Table 85. AstraZeneca Description and Business Overview
Table 86. AstraZeneca Functional Dyspepsia Drug Product
Table 87. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 89. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 90. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 91. AstraZeneca Recent Developments
Table 92. Jiangsu Aosaikang Pharma Company Information
Table 93. Jiangsu Aosaikang Pharma Description and Business Overview
Table 94. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product
Table 95. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 97. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 98. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 99. Jiangsu Aosaikang Pharma Recent Developments
Table 100. Eisai Company Information
Table 101. Eisai Description and Business Overview
Table 102. Eisai Functional Dyspepsia Drug Product
Table 103. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Eisai Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 105. Eisai Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 106. Eisai Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 107. Eisai Recent Developments
Table 108. Kyowa Kirin Pharmaceuticals Company Information
Table 109. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 110. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product
Table 111. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 113. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 114. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 115. Kyowa Kirin Pharmaceuticals Recent Developments
Table 116. Hanmi Pharm Company Information
Table 117. Hanmi Pharm Description and Business Overview
Table 118. Hanmi Pharm Functional Dyspepsia Drug Product
Table 119. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 121. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 122. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 123. Hanmi Pharm Recent Developments
Table 124. North America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 125. North America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 126. North America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 129. North America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 130. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 131. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2026-2031) & (M Units)
Table 132. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 135. Asia-Pacific Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 136. Europe Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 137. Europe Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 138. Europe Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 141. Europe Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 142. Latin America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 143. Latin America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 144. Latin America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 147. Latin America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 148. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 153. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 154. Functional Dyspepsia Drug Key Raw Materials, Industry Status and Trend
Table 155. Functional Dyspepsia Drug Key Raw Materials and Upstream Suppliers
Table 156. Functional Dyspepsia Drug Clients Status and Trend
Table 157. Functional Dyspepsia Drug Typical Clients
Table 158. Functional Dyspepsia Drug Distributors
Table 159. Functional Dyspepsia Drug Market Trends
Table 160. Functional Dyspepsia Drug Market Drivers
Table 161. Functional Dyspepsia Drug Market Challenges
Table 162. Functional Dyspepsia Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Functional Dyspepsia Drug Product Picture
Figure 2. Global Functional Dyspepsia Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Functional Dyspepsia Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Prokinetic Drugs Product Picture
Figure 5. Gastric Antisecretory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Functional Dyspepsia Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Functional Dyspepsia Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Functional Dyspepsia Drug Report Years Considered
Figure 12. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Functional Dyspepsia Drug Market Size 2020-2031 (US$ Million)
Figure 14. Global Functional Dyspepsia Drug Sales 2020-2031 (M Units)
Figure 15. Global Functional Dyspepsia Drug Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 17. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Prokinetic Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 24. Gastric Antisecretory Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Functional Dyspepsia Drug Sales Share by Manufacturer in 2024
Figure 27. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Prokinetic Drugs Market Sales Proportion by Manufacturer in 2024
Figure 29. Gastric Antisecretory Drugs Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 32. North America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 33. North America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 39. Europe Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 41. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 42. Europe Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 43. Europe Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 44. Latin America Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 48. Latin America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 54. Functional Dyspepsia Drug Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Functional Dyspepsia Drug Raw Materials by Region in 2024
Figure 56. Functional Dyspepsia Drug Distribution Channels
Figure 57. Global Functional Dyspepsia Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Functional Dyspepsia Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
